H2AX and metabolic dysfunction-associated steatohepatitis: NAFLD/NASH patients show increases in established hepatocellular senescence markers, including cell cycle arrest (p21) and phosphorylation of histone H2AX (γ-H2AX), which correlate with the severity of the disease [14–16].